Metastatic castration-resistant prostate cancer and the challenge of a patient with chronic kidney disease in hemodialysis
Autops. Case Rep
; 8(2): e2018011, Apr.-May 2018. ilus graf
Article
em En
| LILACS
| ID: biblio-905587
Biblioteca responsável:
BR26.7
ABSTRACT
At a time when the population shows increasing longevity, entities such as cancer and chronic kidney disease (CKD) are more frequently connected. In the United States, approximately 6% of the patients on hemodialysis have cancer. The challenge to manage oncologic patients with CKD in a hemodialytic program represents a great shortage of available information on the choice of the best drug, timing, dosage adjustments, dialysis method, and treatment safety. We present the case of a patient with prostate cancer and terminal CKD in hemodialysis, and the treatment sequence after the development of resistance to hormonal blockade therapy, which included docetaxel, enzalutamide, and radium-223.
Palavras-chave
Texto completo:
1
Temas:
Informacoes_doencas_cronicas_degenerativas
Base de dados:
LILACS
Assunto principal:
Neoplasias da Próstata
/
Adenocarcinoma
/
Diálise
/
Insuficiência Renal Crônica
/
Antineoplásicos
Idioma:
En
Revista:
Autops. Case Rep
Assunto da revista:
Anatomia
/
Patologia Cl¡nica
/
Patologia Legal
Ano de publicação:
2018
Tipo de documento:
Article
País de afiliação:
Portugal